Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Hospital Council of Western Pennsylvania Announces Foundation Radiology Group as Newest Partner

October 18, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 18 /- Foundation Radiology Group (FRG), the region's premier provider of diagnostic imaging services, is pleased to announce that it has been named the Hospital Council of Western Pennsylvania's newest business partner. FRG is a Pittsburgh-based radiology practice that...

Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement

October 18, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

PLANTATION, Fla., Oct. 18 /- Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin...

Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success

October 18, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 18 /- Innovation is the key to success for medical device companies in today's economy. However, not only must companies produce superior products, but they must also effectively manage each product's entire lifecycle to achieve success. This includes...

Advertisement

Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

October 18, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

PARIS and KYOTO, Japan, Oct. 18 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent...

Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

October 17, 2010 8:33 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the...

Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date

October 17, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 15 /- Generex Biotechnology Corporation (Nasdaq: GNBT, www.generex.com ) today announced that it reconvened a special meeting of stockholders (the "Special Meeting") on October 15, 2010 at 10:00 a.m. (local time) at the Meeting Rooms, Westin Harbour Castle Hotel, 1...

New Online Pharmacy RxBuys.com is Launched by One of the Leading Pharmaceutical Companies, Rx Corp

October 17, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Oct. 17 /- The new online pharmacy was launched after the company had studied the market of pharmaceuticals, coming to the conclusion there are not enough reliable and trustworthy places to shop for high quality prescription medications. With the many years of experience...

ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™

October 16, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye...

Advertisement

Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches ...

October 16, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- AdvaMed 2010 : The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global...

Methodist Mansfield Medical Center Donates 4,000 Pedometers for Entire Mansfield ISD Staff

October 15, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

MANSFIELD, Texas, Oct. 15 /- Methodist Mansfield Medical Center will provide a pedometer to every staff member of the Mansfield Independent School District as well as sponsor a Principals' Fitness Challenge program to promote the importance of health and fitness. By helping principals and...

CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall

October 15, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 15 /- CareFusion (NYSE: CFN ), a leading, global medical device company, issued the following update regarding its previously disclosed recall of approximately 17,000 Alaris® PC units model 8015 manufactured or serviced between December 2008 and September 2009. The...

EntreMed Receives Notice of NASDAQ Compliance

October 15, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Oct. 15 /- EntreMed, Inc. (Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum...

Henry Schein to Webcast Third Quarter 2010 Conference Call Friday, October 29, at 10:00 a.m. EDT

October 15, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Oct. 15 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that it will release its third quarter 2010 financial results before the stock market opens on Friday, October 29, 2010,...

Advertisement

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

October 15, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients -- PARIS, October 15, 2010 /-

Kibbutz Shamir and Essilor Sign Agreement

October 15, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

Kibbutz Shamir and Essilor Sign Agreement -- KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, Oct. 15 /-

Cellectis Publishes Its Financial Statement for the First Half of 2010

October 15, 2010 1:31 am | by Bio-Medicine.Org | News | Comments

PARIS, Oct. 15 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro...

Janam Introduces Mobile Healthcare Product Line

October 14, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

WOODBURY, N.Y., Oct. 14 /- Janam Technologies LLC, a leading provider of rugged mobile computers that scan barcodes and communicate wirelessly, today announced a new mobile healthcare solution that extends the company's popular XM Series product line with antimicrobial versions of the...

Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research

October 14, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Oct. 14 /- The U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) has selected Thomson Reuters to develop a secure, interactive tool that will enable researchers to perform comparative effectiveness studies without the need for...

The AACR Congratulates Its Members Elected to the Institute of Medicine

October 14, 2010 11:32 am | by AACR | News | Comments

PHILADELPHIA — The American Association for Cancer Research congratulates 12 of its members on their election into the Institute of Medicine. They are among 65 new members and five foreign associates recently elected.

Generex Provides Clarification for Special Meeting Voting

October 14, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 14 /- Generex Biotechnology Corporation (Nasdaq: GNBT ) ( www.generex.com ) advises its stockholders that votes cast in respect of the reverse stock split proposal put forward at the Annual Meeting of the Company's stockholders held on July 28, 2010 DO NOT COUNT as...

Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research

October 14, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Oct. 14 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced that it is partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). Catherine Chu-Shore, MD, of Massachusetts General Hospital was...

China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders

October 14, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

HARBIN, China, Oct. 14 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...

For the Treatment of Rheumatoid Arthritis, Surveyed European Rheumatologists Expect Well-Established TNF-Alpha Inhibitors to Lose Considerable Patient Share to Newer Agents in...

October 14, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Oct. 14 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, between 2010 and 2013, surveyed European rheumatologists expect well-established TNF-alpha inhibitors to lose considerable patient...

CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates

October 14, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Oct. 14 /- CVS Caremark (NYSE: CVS ) is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading